These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35118754)

  • 1. An unprecedented cause of cardiac resynchronization with defibrillator (CRT-D) malfunction "A beheaded generator assembly".
    Prasitlumkum N; Ding K; Doyle K; Pai RG; Lo R
    J Cardiovasc Electrophysiol; 2022 Apr; 33(4):769-772. PubMed ID: 35118754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malfunction of subpectorally implanted cardiac resynchronization therapy defibrillators due to weakened header bond.
    Hayat SA; Kojodjojo P; Mason A; Benfield A; Wright I; Whinnett Z; Lim PB; Davies DW; Lefroy D; Peters NS; Kanagaratnam P
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):351-5. PubMed ID: 23131091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection and outcome of implantable cardioverter-defibrillator patients with and without cardiac resynchronization therapy: Comparison of 4384 patients from the German Device Registry to randomized controlled trials.
    Köbe J; Willy K; Senges J; Hochadel M; Kleemann T; Spitzer SG; Andresen D; Jehle J; Steinbeck G; Szendey I; Butter C; Brachmann J; Hoffmann E; Eckardt L
    J Cardiovasc Electrophysiol; 2022 Mar; 33(3):483-492. PubMed ID: 35028995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.
    Alam MB; Munir MB; Rattan R; Flanigan S; Adelstein E; Jain S; Saba S
    Europace; 2014 Feb; 16(2):246-51. PubMed ID: 24099864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Battery longevity from cardiac resynchronization therapy defibrillators: differences between manufacturers and discrepancies with published product performance reports.
    Alam MB; Munir MB; Rattan R; Adelstein E; Jain S; Saba S
    Europace; 2017 Mar; 19(3):421-424. PubMed ID: 27009183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased late complex device infections are determined by cardiac resynchronization therapy-defibrillator infection.
    Unsworth JD; Zaidi A; Hargreaves MR
    Europace; 2015 Nov; 17(11):1708-11. PubMed ID: 25883081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cardiac resynchronization therapy and implantable cardioverter defibrillator on quality of life in patients with heart failure: a meta-analysis.
    Chen S; Yin Y; Krucoff MW
    Europace; 2012 Nov; 14(11):1602-7. PubMed ID: 23104857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes in cardiac resynchronization therapy-defibrillator recipients 80 years of age and older.
    Adelstein EC; Liu J; Jain S; Schwartzman D; Althouse AD; Wang NC; Gorcsan J; Saba S
    Europace; 2016 Mar; 18(3):420-7. PubMed ID: 26487669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mortality analysis of primary prevention patients receiving a cardiac resynchronization defibrillator (CRT-D) or implantable cardioverter-defibrillator (ICD) according to guideline indications in the improve SCA study.
    Ching CK; Hsieh YC; Liu YB; Rodriguez DA; Kim YH; Joung B; Singh B; Huang D; Hussin A; Chasnoits AR; O'Brien JE; Cerkvenik J; Lexcen D; Van Dorn B; Zhang S
    J Cardiovasc Electrophysiol; 2021 Aug; 32(8):2285-2294. PubMed ID: 34216069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deterioration from improved heart failure status in a recipient of a cardiac resynchronization therapy-defibrillator (CRT-D) following a single inappropriate shock.
    Kantharia BK
    Int J Cardiol; 2012 Nov; 161(3):e55-7. PubMed ID: 22546544
    [No Abstract]   [Full Text] [Related]  

  • 14. Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes.
    Jędrzejczyk-Patej E; Mazurek M; Kotalczyk A; Kowalska W; Konieczny-Kozielska A; Kozielski J; Podolecki T; Szulik M; Sokal A; Kowalski O; Kalarus Z; Średniawa B; Lenarczyk R
    Europace; 2021 Jan; 23(1):113-122. PubMed ID: 33257952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database.
    Boriani G; Ritter P; Biffi M; Ziacchi M; Diemberger I; Martignani C; Valzania C; Valsecchi S; Padeletti L; Gadler F
    Europace; 2016 Sep; 18(9):1366-73. PubMed ID: 26847076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
    Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.
    Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F
    Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.
    Kramer DB; Normand ST; Volya R; Hatfield LA
    Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004763. PubMed ID: 30562069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity and mortality with cardiac resynchronization therapy with pacing vs. with defibrillation in octogenarian patients in a real-world setting.
    Laish-Farkash A; Bruoha S; Katz A; Goldenberg I; Suleiman M; Michowitz Y; Shlomo N; Einhorn-Cohen M; Khalameizer V
    Europace; 2017 Aug; 19(8):1357-1363. PubMed ID: 27733457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One Indication for an Extravascular Cardiac Resynchronization Therapy Defibrillator: Lessons from a Combination Therapy Case with Epicardial Cardiac Resynchronization Therapy and a Subcutaneous Implantable Cardioverter Defibrillator.
    Ishii N; Nakajima K; Kakuta T; Noda T; Fujita T; Kusano K
    Intern Med; 2021 Jun; 60(12):1877-1880. PubMed ID: 33518564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.